Sygnature Discovery

Contract research organization (CRO) · Nottingham, England, United Kingdom

Sygnature Discovery is a contract research organization (CRO) headquartered in Nottingham, England, United Kingdom. Its earliest recorded incorporation is in 2004. It is registered with UK Companies House under company number 05210563.

www.sygnaturediscovery.comProfile compiled from public records. Is this your company? Request a correction or update

Sygnature Discovery at a glance

Typecontract research organization (CRO)
HeadquartersNottingham, England, United Kingdom
Earliest incorporation on record2004
Registered activities (UK)Research and experimental development on biotechnology
UK company number05210563

Sygnature Discovery on the BioBridgeX marketplace

CRO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead

Services

Target ID & ValidationAssay Development & ScreeningHit-to-LeadLead OptimizationMedicinal & Synthetic ChemistryComputational / AI-Driven DiscoveryStructural BiologyProtein Sciences & ReagentsIn Vitro PharmacologyDMPK / ADMEPK/PD & ModelingBiomarker Discovery & Development

Therapeutic areas

OncologyCNS / NeurologyImmunology & InflammationMetabolic / EndocrinologyRespiratoryRare / Orphan DiseaseInfectious Disease

Modalities

Small MoleculePeptidePROTAC / Targeted Protein DegraderOligonucleotide (ASO / siRNA)
Compare quotes

Unclaimed listing. Claim this profile

Frequently asked questions about Sygnature Discovery

Where is Sygnature Discovery headquartered?

Sygnature Discovery is headquartered in Nottingham, England, United Kingdom.

What does Sygnature Discovery do?

Sygnature Discovery is a contract research organization (CRO).

When was Sygnature Discovery founded?

The earliest incorporation on record for Sygnature Discovery is in 2004, according to public company registers.

Similar companies

Sources

Contains public sector information licensed under the Open Government Licence v3.0 (UK Companies House).

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.